Quick Takeaways
- Carole Nuechterlein has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Carole Nuechterlein
- Location
- Bannockburn, IL
- Signature
- /s/ Lesley Ann Calhoun, as attorney-in fact for Carole Nuechterlein
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Carole Nuechterlein and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Aligos Therapeutics, Inc. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Carole Nuechterlein
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics, Inc. | Director | 25 Jun 2025 | |||
| TRDA | Entrada Therapeutics, Inc. | Director | 02 Jun 2022 |
Insider Transactions Reported by Carole Nuechterlein:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.